Logo

Janssen Collaborates with PhysIQ for Wearable Biosensors and Digital Biomarkers Initiatives

Share this

Janssen Collaborates with PhysIQ for Wearable Biosensors and Digital Biomarkers Initiatives

Shots:

  • Janssen gets license to utilize physIQ’s accelerateIQ platform to gather data from clinical studies through different wearable biosensors. The platform is powered by FDA-cleared digital biomarkers that helps to transform raw data into clinical insight
  • The platform’s findings can be used to advance subsequent research projects and will support both R&D and commercial strategies
  • The collaboration will boost the ability to bring new treatments to market and enable commercial strategies that integrate digital medicine into patient care

  Ref: Business Wire | Image: Janssen

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions